-+ 0.00%
-+ 0.00%
-+ 0.00%

ALUMIS shares plummeted 53% as its lupus drug failed to meet mid-term trial targets.

Zhitongcaijing·09/01/2026 13:41:24
Listen to the news
ALUMIS shares plummeted 53% as its lupus drug failed to meet mid-term trial targets.